
### [NCIT:C136632](http://purl.obolibrary.org/obo/NCIT_C136632)
**Label:** Bone Sarcoma by AJCC v7 Stage

**Subclasses:** [NCIT:C6705](http://purl.obolibrary.org/obo/NCIT_C6705) (Stage II Bone Sarcoma  AJCC v7), [NCIT:C6704](http://purl.obolibrary.org/obo/NCIT_C6704) (Stage I Bone Sarcoma  AJCC v7), [NCIT:C6468](http://purl.obolibrary.org/obo/NCIT_C6468) (Stage III Bone Sarcoma  AJCC v7), [NCIT:C6710](http://purl.obolibrary.org/obo/NCIT_C6710) (Stage II Osteosarcoma  AJCC v7), [NCIT:C6701](http://purl.obolibrary.org/obo/NCIT_C6701) (Stage IV Osteosarcoma  AJCC v7), [NCIT:C136633](http://purl.obolibrary.org/obo/NCIT_C136633) (Osteosarcoma by AJCC v7 Stage), [NCIT:C6612](http://purl.obolibrary.org/obo/NCIT_C6612) (Stage III Osteosarcoma  AJCC v7), [NCIT:C6706](http://purl.obolibrary.org/obo/NCIT_C6706) (Stage IV Bone Sarcoma  AJCC v7), [NCIT:C6709](http://purl.obolibrary.org/obo/NCIT_C6709) (Stage I Osteosarcoma  AJCC v7), 

**Class expressions from DL-Learner:**

- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 53.57%
- Thing 53.00%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39625](http://purl.obolibrary.org/obo/NCIT_C39625) (Extracutaneous Dissemination of Disease))) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39624](http://purl.obolibrary.org/obo/NCIT_C39624) (Skin Plaque))) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39622](http://purl.obolibrary.org/obo/NCIT_C39622) (Scaly Skin Eruption))) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39620](http://purl.obolibrary.org/obo/NCIT_C39620) (Dermatopathic Lymphadenopathy))) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39618](http://purl.obolibrary.org/obo/NCIT_C39618) (Subcutaneous Nodule))) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39617](http://purl.obolibrary.org/obo/NCIT_C39617) (Subcutaneous Involvement))) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39616](http://purl.obolibrary.org/obo/NCIT_C39616) (Karyorrhexis))) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39615](http://purl.obolibrary.org/obo/NCIT_C39615) (Sinusoidal Infiltration))) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39609](http://purl.obolibrary.org/obo/NCIT_C39609) (Activated Natural Killer Cell))) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39608](http://purl.obolibrary.org/obo/NCIT_C39608) (Coagulative Necrosis))) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39602](http://purl.obolibrary.org/obo/NCIT_C39602) (Pleomorphic Medium-Sized to Large T-Lymphocyte))) 38.93%
- [UBERON:0000310](http://purl.obolibrary.org/obo/UBERON_0000310) (breast) and (not ([NCIT:C39600](http://purl.obolibrary.org/obo/NCIT_C39600) (Neoplastic Medium-Sized T-Lymphocyte))) 38.93%


